TIME INTERVAL BETWEEN REPEATED INJECTIONS CONDITIONS THE DURATION OF MOTOR IMPROVEMENT TO APOMORPHINE IN PARKINSONS-DISEASE

被引:34
作者
GRANDAS, F
GANCHER, S
LERA, G
RODRIGUEZ, M
WOODWARD, WR
NUTT, J
OBESO, JA
机构
[1] UNIV NAVARRA CLIN,DEPT NEUROL,MOVEMENT DISORDERS UNIT,APDO 192,E-31080 PAMPLONA,SPAIN
[2] OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201
关键词
D O I
10.1212/WNL.42.7.1287
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Behavioral hyposensitivity to repeated apomorphine administration occurs in fluctuating parkinsonian patients. To determine to what extent the interval between doses influences the response, we administered equal paired apomorphine injections to 10 fluctuating parkinsonian patients. Subjects received two apomorphine injections at 2-hour and at 4-hour intervals on different days after a 10- to 12-hour overnight period without levodopa. Following apomorphine doses at 2-hour intervals, the duration of response was reduced by 40% (61 versus 42 minutes, p < 0.001) but was of equal duration when the doses were given at 4-hour intervals. These findings indicate that the interval between doses is a critical determinant of motor response. We postulate a time-dependent period of partial hyposensitivity to pulsatile DA stimulation.
引用
收藏
页码:1287 / 1290
页数:4
相关论文
共 16 条
  • [11] THE MOTOR RESPONSE TO SEQUENTIAL APOMORPHINE IN PARKINSONIAN FLUCTUATIONS
    HUGHES, AJ
    LEES, AJ
    STERN, GM
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1991, 54 (04) : 358 - 360
  • [12] THE MOTOR RESPONSE TO REPEATED APOMORPHINE ADMINISTRATION IN PARKINSONS-DISEASE
    HUGHES, AJ
    BISHOP, S
    STERN, GM
    LEES, AJ
    [J]. CLINICAL NEUROPHARMACOLOGY, 1991, 14 (03) : 209 - 213
  • [13] ERRATIC GASTRIC-EMPTYING OF LEVODOPA MAY CAUSE RANDOM FLUCTUATIONS OF PARKINSONIAN MOBILITY
    KURLAN, R
    ROTHFIELD, KP
    WOODWARD, WR
    NUTT, JG
    MILLER, C
    LICHTER, D
    SHOULSON, I
    [J]. NEUROLOGY, 1988, 38 (03) : 419 - 421
  • [14] ASSESSMENT OF EXTRAPYRAMIDAL DISORDERS
    MARSDEN, CD
    SCHACHTER, M
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (02) : 129 - 151
  • [15] MUENTER MD, 1971, MAYO CLIN PROC, V46, P231
  • [16] NUTT JG, 1984, NEW ENGL J MED, V310, P438